The T790M mutation is a specific genetic alteration found in the EGFR (epidermal growth factor receptor) gene. This mutation is most commonly associated with non-small cell lung cancer (NSCLC). The presence of T790M generally indicates resistance to first and second-generation EGFR tyrosine kinase inhibitors (TKIs), making it a significant factor in cancer treatment and prognosis.